Showing results (121-130 of 167) with videos related to

Sort By:
Pageof 17
Cell Death & Disease|December 5, 2024
SENP3-FIS1 axis promotes mitophagy and cell survival under hypoxiaAlice Zhao, Laura Maple, Juwei Jiang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 8, 2017
Effects of biodegradable hydrogel spacer injection on contralateral submandibular gland sparing in radiotherapy for head and neck cancersAvani D Rao, Stephanie Coquia, Robert De Jong, et al.
Journal of Cell Science|March 19, 2020
EML4-ALK V3 oncogenic fusion proteins promote microtubule stabilization and accelerated migration through NEK9 and NEK7Laura O'Regan, Giancarlo Barone, Rozita Adib, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2019
Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins ExperienceMatthew P Deek, Colburn Yu, Ryan Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2016
Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing RadiationMohammad Hedayati, Michael C Haffner, Jonathan B Coulter, et al.
Journal of Cell Science|May 13, 2014
Ccdc13 is a novel human centriolar satellite protein required for ciliogenesis and genome stabilityChristopher J Staples, Katie N Myers, Ryan D D Beveridge, et al.
Neuro-Oncology Practice|August 15, 2025
Race and "omic" data in glioma: A systematic review of contemporary research to explore the digital divideOlaoluwa Ezekiel Dada, Zvipo Chisango, Kwadwo Antwi Boasiako Nkansah-Poku, et al.
International Journal of Radiation Oncology, Biology, Physics|September 26, 2013
Combined treatment effects of radiation and immunotherapy: studies in an autochthonous prostate cancer modelSatoshi Wada, Timothy J Harris, Erik Tryggestad, et al.
Cell|October 30, 2008
RTEL1 maintains genomic stability by suppressing homologous recombinationLouise J Barber, Jillian L Youds, Jordan D Ward, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkersEmmanuel S Antonarakis, Elisabeth I Heath, Janet R Walczak, et al.
Pageof 17